Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jeff Behrens
Observed names:
Behrens, Jeff,
J. Behrens
Institution:
Siamab Therapeutics (United States)
Observed institutions:
Harvard University,
Massachusetts General Hospital,
Siamab Therapeutics (United States),
Edimer Pharmaceuticals (United States)
OpenAlex ID:
A5063291035
Novel anti-Sialyl-Tn monoclonal antibodies and antibody-drug conjugates demonstrate tumor specificity and anti-tumor activity
2017
·
Jillian M. Prendergast
, Ana Paula Galvao da Silva
, et al.
·
mAbs
·
85
PDF
Humanized anti-Sialyl-Tn antibodies for the treatment of ovarian carcinoma
2018
·
David A. Eavarone
, Linah Al-Alem
, et al.
·
PLoS ONE
·
45
PDF
Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau
2018
·
Kristen Starbuck
, Linah Al-Alem
, et al.
·
Oncotarget
·
34
PDF
Sialyl-Tn serves as a potential therapeutic target for ovarian cancer
2024
·
Linah Al-Alem
, Jillian M. Prendergast
, et al.
·
Journal of Ovarian Research
·
19
PDF
Abstract 3640: Novel humanized anti-Sialyl-Tn, anti-CD3 bispecific antibodies demonstrate tumor and T-cell specificity for immune activation at the tumor site
2017
·
David A. Eavarone
, Jillian Prendergast
, et al.
·
Cancer Research
·
3
Abstract 5625: Myeloid derived suppressor cells (MDSCs) express Sialyl Tn (STn) and are a therapeutic target for anti-STn antibody drug conjugates
2018
·
David A. Eavarone
, Patricia E. Rao
, et al.
·
Cancer Research
·
1
Eradicating ovarian cancer stem cells by targeting the tumor-associated carbohydrate antigen sialyl Tn
2015
·
K. Starbuck
, D. Eavarone
, et al.
·
Gynecologic Oncology
·
1
Abstract LB-229: Utilizing a novel highly specific sialyl-Tn ELISA as a diagnostic for ovarian cancer
2019
·
Linah F. Al-Alem
, Jillian Prendergast
, et al.
·
Cancer Research
Abstract LB-229: Utilizing a novel highly specific sialyl-Tn ELISA as a diagnostic for ovarian cancer
2019
·
Linah F. Al-Alem
, Jillian Prendergast
, et al.
·
Clinical Research (Excluding Clinical Trials)
Abstract B28: Targeting the tumor-associated carbohydrate antigen STn with humanized anti-Sialyl-Tn monoclonal antibody-drug conjugates inhibits ovarian cancer tumor growth in vitro and in vivo
2018
·
Daniel T. Dransfield
, Jillian M. Prendergast
, et al.
·
Clinical Cancer Research
Abstract B114: Humanized anti-Sialyl-Tn monoclonal antibody-drug conjugates inhibit tumor growth in vitro and in vivo
2018
·
Daniel Dransfield
, Jillian M. Prendergast
, et al.
·
Molecular Cancer Therapeutics
Abstract 36: Novel anti-Sialyl-Tn monoclonal antibodies and antibody-drug conjugates (ADCs) demonstrate tumor specificity in vitro and in vivo antitumor efficacy
2017
·
Jillian M. Prendergast
, David A. Eavarone
, et al.
·
Cancer Research
Abstract MIP-071: TARGETING A CHEMORESISTANT OVARIAN CANCER CELL POPULATION VIA THE CARBOHYDRATE ANTIGEN SIALYL TN
2017
·
B.R. Rueda
, K. Starbuck
, et al.
·
Clinical Cancer Research
Abstract LB-221: Novel anti-Sialyl-Tn monoclonal antibodies and antibody-drug conjugates (ADCs) demonstrate tumor specificity, unique sequence homology and in vitro and in vivo antitumor efficacy
2016
·
David Eaverone
, Jeff Behrens
, et al.
·
Cancer Research
479 The discovery and development of potent and specific anti-SialylTn antibodies for the treatment of solid tumors
2014
·
K. Meetze
, D. Ghaderi
, et al.
·
European Journal of Cancer
Practical Aspects of Developing In-Licensed Pharmaceutical Products
2012
·
Neil Kirby
, Rebecca Dabora
, et al.
·
Elsevier eBooks
Show more works
View as search
Works count:
26
Citation count:
188
H-index:
4
I10-index:
4
Year
Topic
Type